Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians

Diabetologia

Volumn 45, Issue 11, 2002, Pages 1584-1593

  Yang, X ^a,b,c   Pratley, R ^a,b,c   Tokraks, S ^a,b,c   Bogardus, C ^a,b,c   Permana, P ^a,b,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Diabetes; Genes; Insulin resistance; Oligonucleotide array; RT PCR

Indexed keywords

INSULIN; MESSENGER RNA; ENZYME; PROTEIN;

ADULT; ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; DIABETES MELLITUS; DNA MICROARRAY; ETHNIC GROUP; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANK SUM TEST; RISK FACTOR; SKELETAL MUSCLE; AMERICAN INDIAN; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; PHYSIOLOGY; UNITED STATES;

ADULT; ARIZONA; BLOOD GLUCOSE; ENZYMES; GENE EXPRESSION PROFILING; GLUCOSE TOLERANCE TEST; HUMANS; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; MUSCLE, SKELETAL; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0036435899     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0905-7     Document Type: Article

References (62)

1. Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104: 517-529
2. Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988-1992
3. Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505
4. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
5. Lillioja S, Bogardus C (1988) Obesity and insulin resistance: Lessons learned from the Pima Indians. Diabetes Metab Rev 4:517-540
6. Kahn CR, Vicent D, Doria A (1996) Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 47:509-531
7. Pratley RE, Thompson DB, Prochazka M et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 101:1757-1764
8. Hanson RL, Ehm MG, Pettitt DJ et al. (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130-1138
9. Alon U, Barkai N, Notterman DA et al. (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96:6745-6750
10. Thykjaer T, Workman C, Kruhoffer M et al. (2001) Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61:2492-2499
11. Wilson SB, Kent SC, Horton HF et al. (2000) Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 97:7411-7416
12. Tataranni PA, Ravussin E (1995) Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr 62:730-734
13. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
14. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
15. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246
16. Bogardus C, Lillioja S, Ravussin E et al. (1986) Familial dependence of the resting metabolic rate. N Engl J Med 315:96-100
17. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491-503
18. Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M (2000) Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol Genomics 2:143-147
19. Valerius MT, Patterson LT, Witte DP, Potter SS (2002) Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation. Mech Dev 112:219-232
20. Schadt EE, Li C, Su C, Wong WH (2000) Analyzing high-density oligonucleotide gene expression array data. J Cell Biochem 80:192-202
21. Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. John Wiley & Sons, New York
22. Claverie JM (1999) Computational methods for the identification of differential and coordinated gene expression. Hum Mol Genet 8:1821-1832
23. Ducluzeau PH, Perretti N, Laville M et al. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50:1134-1142
24. Huang X, Vaag A, Hansson M, Groop L (2002) Down-regulation of insulin receptor substrates (IRS)-1 and IRS-2 and Src homologous and collagen-like protein Shc gene expression by insulin in skeletal muscle is not associated with insulin resistance or type 2 diabetes. J Clin Endocrinol Metab 87:255-259
25. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O (1993) Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828-832
26. Hitman GA, Hawrami K, McCarthy MI et al. (1995) Insulin receptor substrate-1 gene mutations in NIDDM: Implications for the study of polygenic disease. Diabetologia 38:481-486
27. Shimokawa K, Kadowaki H, Sakura H et al. (1994) Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 202:463-469
28. Ito K, Katsuki A, Furuta M et al. (1999) Insulin sensitivity is not affected by mutation of codon 972 of the human IRS-1 gene. Horm Res 52:230-234
29. Celi FS, Silver K, Walston J, Knowler WC, Bogardus C, Shuldiner AR (1995) Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians. J Clin Endocrinol Metab 80:2827-2829
30. Kovacs P, Yang X, Permana PA, Kobes S, Bogardus C, Baier LJ (2002) Variants in the insulin receptor substrate-1 gene are associated with type 2 diabetes in Pima Indians. Diabetes 51 (Suppl 2):A266
31. Alessi DR, Street AJ, Cohen P, Cohen PT (1993) Inhibitor-2 functions like a chaperone to fold three expressed isoforms of mammalian protein phosphatase-1 into a conformation with the specificity and regulatory properties of the native enzyme. Eur J Biochem 213:1055-1066
32. MacKintosh C, Garton AJ, McDonnell A et al. (1996) Further evidence that inhibitor-2 acts like a chaperone to fold PP1 into its native conformation. FEBS Lett 397:235-238
33. Kakinoki Y, Somers J, Brautigan DL (1997) Multisite phosphorylation and the nuclear localization of phosphatase inhibitor 2-green fluorescent protein fusion protein during S phase of the cell growth cycle. J Biol Chem 272:32308-32314
34. Permana PA, Mott DM (1997) Genetic analysis of human type 1 protein phosphatase inhibitor 2 in insulin-resistant Pima Indians. Genomics 41:110-114
35. Zhang J, Zhang L, Zhao S, Lee EY (1998) Identification and characterization of the human HCG V gene product as a novel inhibitor of protein phosphatase-1. Biochemistry 37:16728-16734
36. Helps NR, Street AJ, Elledge SJ, Cohen PT (1994) Cloning of the complete coding region for human protein phosphatase inhibitor 2 using the two hybrid system and expression of inhibitor 2 in E. coli. FEBS Lett 340:93-98
37. Sanseau P, Jackson A, Alderton RP et al. (1994) Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences. Mamm Genome 5:490-496
38. James PL, Stewart CE, Rotwein P (1996) Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J Cell Biol 133:683-693
39. Rotwein P, James PL, Kou K (1995) Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol Endocrinol 9:913-923
40. Imai Y, Moralez A, Andag U, Clarke JB, Busby WH Jr, Clemmons DR (2000) Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275:18188-18194
41. Jehle PM, Jehle DR, Mohan S, Bohm BO (1998) Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol 159:297-306
42. Bach LA, Dean R, Youssef S, Cooper ME (2000) Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy. Nephrol Dial Transplant 15:347-354
43. Coenen Schimke JM, Ljungqvist OH, Sarkar G, Conover CA, Sreekumaran NK (1999) A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle. Growth Horm IGF Res 9:179-186
44. Kovaks P, Yang X, Permana PA, Bogardus C, Baier LJ (2001) A Rho-associated guanine exchange factor is associated with insulin resistance in non-diabetic Pima Indians. Diabetes 50:A245
45. Condorelli G, Vigliotta G, Iavarone C et al. (1998) PED/PEA-15 gene controls glucose transport and is over-expressed in type 2 diabetes mellitus. EMBO J 17:3858-3866
46. Wolford JK, Bogardus C, Ossowski V, Prochazka M (2000) Molecular characterization of the human PEA15 gene on 1q21-q22 and association with type 2 diabetes mellitus in Pima Indians. Gene 241:143-148
47. Pedersen O, Bak JF, Andersen PH et al. (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870
48. Stuart CA, Wen G, Williamson ME et al. (2001) Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4: Protein in muscle from patients with acanthosis nigricans and severe insulin resistance. Metabolism 50:771-777
49. Vestergaard H, Bjorbaek C, Hansen T, Larsen FS, Granner DK, Pedersen O (1995) Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 96:2639-2645
50. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O (1991) Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40:1740-1745
51. Majer M, Mott DM, Mochizuki H et al. (1996) Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia 39:314-321
52. Reynet C, Kahn CR (1993) Rad: A member of the Ras family overexpressed in muscle of type II diabetic humans. Science 262:1441-1444
53. Paulik MA, Hamacher LL, Yarnall DP et al. (1997) Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians. J Cell Biochem 65:527-541
54. Bao S, Kennedy A, Wojciechowski B, Wallace P, Ganaway E, Garvey WT (1998) Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: Effects of obesity and diabetes. Diabetes 47:1935-1940
55. Baier LJ, Permana PA, Yang X et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73
56. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA (1996) The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116
57. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR (1997) PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46:1230-1234
58. Kellerer M, Sesti G, Seffer E et al. (1993) Altered pattern of insulin receptor isotypes in skeletal muscle membranes of Type II (non-insulin-dependent) diabetic subjects. Diabetologia 36:628-632
59. Chen YH, Hansen L, Chen MX et al. (1994) Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes 43:1234-1241
60. Xia J, Scherer SW, Cohen PT et al. (1998) A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes 47:1519-1524
61. Frittitta L, Sbraccia P, Costanzo BV et al. (2000) High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells. Diabetes Metab Res Rev 16:26-32
62. White JA, McAlpine PJ, Antonarakis S et al. (1997) Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics 45:468-471